UK-headquartered, US-listed Clarivate’s stock price rose by almost 40% on the release of the firm’s decision to sell its Life Sciences & Healthcare business from US$1.68 to US$2.35. In its…
UK: Clarivate shares jump higher on announcement of plans to sell Life Sciences & Healthcare business
…
…






